Aug 04, 2022 / 11:00AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Q1 FY '23 Financial Results Conference Call of Alembic Pharmaceuticals Limited. We have with us from the management, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head of Finance; Mr. Jesal Shah, Head, Strategy; and Mr. Ajay Kumar Desai, Senior VP, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thanks. Good evening, everyone. Thank you for joining our first quarter for 2022-'23 quarterly results conference call. I'm sure you would have received the results by now. I know the financial numbers are bit below your expectations. But during this call, we'll try to explain you the reasons. And also the rationale why we think the underlying business is robust. So, first of all financials.
Q1 2023 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Aug 04, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers